Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06385886 · ClinicalTrials.gov registry record

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

A clinical trial of Sickle Cell Disease, sponsored by RTI International.

Recruiting
Registry status
500
Enrollment target
9
Study locations

NCT06385886 is a study of Sickle Cell Disease that is actively recruiting participants, run by RTI International. The registered enrollment target is 500 participants, above the 290-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (72% higher). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06385886, a study of Sickle Cell Disease, is actively recruiting participants, sponsored by RTI International.

RECRUITING
Registry status
500 participants
Enrollment target
9
Study locations

Study Summary

The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once unaffiliated individuals are found using the pathways, Investigators will employ linkage coordinators (trained staff) to engage these patients in care. Participants will be asked to fill out an assessment survey which will cover areas such as previous and current treatment, clinic and hospital experience, pain, and quality of life. Participants will also be given the option of participation in a 1-hour long interview how they feel about treatment for sickle cell disease including clinic experience, pain, and quality of life?

Conditions Studied

Sickle Cell Disease

Interventions

  • BEHAVIORAL Linkage Coordinator

Study Locations (9)

Alabama

  • University of Alabama, Birmingham (UAB) - Birmingham

Arizona

  • Phoenix Children's Hospital - Phoenix

California

  • University of California, San Francisco (UCSF) - Oakland

Georgia

  • Augusta University - Augusta

Illinois

  • University of Illinois - Chicago

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • University of Pennsylvania - Philadelphia

Tennessee

  • University of Tennessee at Memphis - Memphis

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-06-08
Est. Completion 2027-12

Sponsor

RTI International

45 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06385886

The ClinicalTrials.gov registry entry for NCT06385886 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 290-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (72% higher). The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Linkage Coordinator is the first listed.

NCT06385886 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Alabama, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT06385886 about?

NCT06385886 is a clinical study titled "Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease". The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once ...

What is the current status of trial NCT06385886?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-06-08. Estimated completion is 2027-12.

What conditions does trial NCT06385886 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT06385886?

The interventions under investigation include: Linkage Coordinator (BEHAVIORAL).

Who is sponsoring clinical trial NCT06385886?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06385886 being conducted?

This trial has 9 study locations across Alabama, Arizona, California, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.